Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in increased expression of GREB1 mRNA | increases expression | 16496412
|
C447119 |
bazedoxifene acetate |
bazedoxifene acetate results in decreased expression of GREB1 mRNA | decreases expression | 19914376
|
C053541 |
bicalutamide |
bicalutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of GREB1 mRNA | increases expression | 16474171
|
D017373 |
Cyproterone Acetate |
Cyproterone Acetate inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of GREB1 mRNA | increases expression | 19371625
|
D004958 |
Estradiol |
Estradiol affects the expression of GREB1 mRNA | affects expression | 14699072
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GREB1 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol promotes the reaction [ESR1 protein binds to GREB1 enhancer] | affects binding|increases reaction | 20068169
|
D004958 |
Estradiol |
Estradiol results in increased expression of GREB1 mRNA | increases expression | 16474171 19619570 20068169 15986123 15849065 17283378
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of GREB1 mRNA | affects cotreatment|increases expression | 17404688
|
D004958 |
Estradiol |
sodium arsenite inhibits the reaction [Estradiol results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 17283378
|
D004958 |
Estradiol |
TBX21 protein inhibits the reaction [Estradiol promotes the reaction [ESR1 protein binds to GREB1 enhancer]] | affects binding|decreases reaction|increases reaction | 20068169
|
D004958 |
Estradiol |
TBX21 protein inhibits the reaction [Estradiol results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 20068169
|
D015025 |
Zearalenone |
Zearalenone results in increased expression of GREB1 mRNA | increases expression | 19371625
|
D005485 |
Flutamide |
Flutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
D019833 |
Genistein |
Genistein results in increased expression of GREB1 mRNA | increases expression | 16474171 19371625
|
C533894 |
LG 100815 |
LG 100815 results in decreased expression of GREB1 mRNA | decreases expression | 16951191
|
D015741 |
Metribolone |
Metribolone results in increased expression of GREB1 mRNA | increases expression | 16496412
|
C021277 |
nilutamide |
nilutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
C062198 |
octa-2,4,6-trienoic acid |
octa-2,4,6-trienoic acid results in decreased expression of GREB1 mRNA | decreases expression | 16951191
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of GREB1 mRNA | increases expression | 16474171
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of GREB1 mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of GREB1 mRNA | increases expression | 17404688
|
C017947 |
sodium arsenite |
sodium arsenite inhibits the reaction [Estradiol results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 17283378
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of GREB1 mRNA | decreases expression | 17283378
|
D013739 |
Testosterone |
bicalutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
D013739 |
Testosterone |
Cyproterone Acetate inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
D013739 |
Testosterone |
Flutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
D013739 |
Testosterone |
nilutamide inhibits the reaction [Testosterone results in increased expression of GREB1 mRNA] | decreases reaction|increases expression | 16496412
|
D013739 |
Testosterone |
Testosterone results in increased expression of GREB1 mRNA | increases expression | 16496412
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GREB1 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GREB1 mRNA | decreases expression | 19619570
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.79 | 14514962 15322242 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.41 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
4.41 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.32 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.64 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.85 | 16712894 17306315 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.42 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.80 | 7506515 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.98 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.72 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.80 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.28 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.19 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.73 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
3.73 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.73 | 18497071 12948864 17261762 17289903 19861407 16675129 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
3.73 | 17200150 16541309 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.73 | 16175315 17614352 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
3.73 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.73 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.40 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
6.53 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.53 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
6.53 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.53 | 16507464 17306315 15276417 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.93 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.36 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.33 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.26 | 16332659 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.59 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.59 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.65 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 15668235 15340226 8697196 16354765 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.28 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
2.73 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.49 | 12952375 16002989 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.64 | 16140633 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.27 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.27 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.35 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.43 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.52 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.71 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.32 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.72 | 17692515 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
11.69 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
11.69 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
12.27 | 15700306 16804899 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.27 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
12.27 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.73 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.73 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.61 | 16534752 16611131 15751030 16513791 16002989 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.89 | 20067830 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.80 | 7506515 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
12.61 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
12.61 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.45 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
7.45 | 17162496 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.30 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.83 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.98 | 15709030 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.60 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.10 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.70 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 15340226 18606429 8697196 16354765 16959395 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
12.04 | 15356085 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
12.04 | 17019078 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.37 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.88 | 18670907 18850075 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.54 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
6.15 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.52 | 16002989 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.80 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.34 | 15869954 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.29 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.94 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Progesterone |
4.86 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.86 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.29 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.29 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.98 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.98 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
7.36 | 14681315 15003126 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.36 | 15610895 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
4.00 | 17184923 |
MESH:D007938 |
Leukemia |
|
Genistein |
2.99 | 18980019 17468513 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.43 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.43 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.43 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
7.32 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.32 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.32 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
5.98 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.98 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.13 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.28 | 16712894 15276417 17306315 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.28 | 11884234 19555203 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
5.09 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
3.42 | 15700306 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.46 | 16002989 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.76 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.76 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.76 | 17203775 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.43 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.02 | 16487513 19082730 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.83 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.96 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.34 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.34 | 17141266 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
5.13 | 15313581 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.13 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.60 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.67 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
30.08 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
30.08 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
30.08 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
30.08 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
30.08 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.10 | 12854658 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.21 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.02 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.93 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.14 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.14 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
11.14 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.14 | 17306315 15276417 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.37 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
5.11 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.61 | 15687265 16977796 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
4.94 | 15356085 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
15.93 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
15.93 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
15.93 | 11222880 11896295 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
17.70 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
17.70 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
17.70 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 16496412 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
2.46 | 15638997 17914592 19011039 19240160 18487222 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.46 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
2.46 | 17136230 15846301 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.46 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
2.46 | 3169114 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.46 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.46 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.46 | 16039940 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.72 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.83 | 18045962 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
6.15 | 16631401 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.49 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.49 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.66 | 16002989 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.22 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.74 | 12854658 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.92 | 16684133 16045194 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.63 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
5.19 | 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.19 | 17306315 16452187 16712894 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
9.34 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.34 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
13.63 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
13.63 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
4.00 | 15809267 16690809 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.37 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.36 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |